Dr. Woller joined the National Institute of Neurological Disorders and Stroke (NINDS) Division of Translational Research (DTR) in March 2019 and currently serves as the Scientific Project Manager for the Preclinical Screening Platform for Pain (PSPP).
Dr. Woller completed her Ph.D. at Texas A&M University where her dissertation work focused on understanding the addictive potential of morphine following spinal cord injury (SCI), and how opioid administration contributes to the development of pain and affects locomotor recovery after SCI. After completion of her Ph.D., Dr. Woller began a postdoctoral fellowship at the University of California, San Diego (UCSD) on a Ruth L. Kirschstein Institutional National Research Service Award. At UCSD, she conducted in vivo studies using pharmacologic and genetic manipulations to examine mechanisms underlying the transition from acute to chronic pain with a focus on rheumatoid arthritis, chemotherapeutic-induced peripheral neuropathy, and sex-differences. Most recently, Dr. Woller was the Associate Director of Preclinical Research at a clinical stage biopharmaceutical company where she led a team responsible for in vivo proof-of-concept studies, including validation of critical biomarkers and IND-enabling studies for drug candidates with indications in neurovascular disorders and neurotrauma.